Bacithrocins A, B and C, Novel Thrombin Inhibitors
Overview
Pharmacology
Affiliations
Novel thrombin inhibitors, bacithrocins A, B and C, have been isolated from the culture broth of Bacillus laterosporus Laubach NR 2988. The structures of these inhibitors have been determined to be N-acyl-L-phenylalanyl-DL-arginal by the 2D-NMR experiments on their oxidation products and by amino acid analysis. Bacithrocin A inhibits thrombin, factor Xa and trypsin with IC50s of 48, 13 and 0.65 microM, respectively, which are similar to those of bacithrocins B and C. Bacithrocins prolong the clotting time induced by thrombin and factor Xa.
Aguilar C, Verdel-Aranda K, Ramos-Aboites H, Licona-Cassani C, Barona-Gomez F J Ind Microbiol Biotechnol. 2023; 50(1).
PMID: 37669898 PMC: 10548850. DOI: 10.1093/jimb/kuad021.
Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10.
Baindara P, Gautam A, Raghava G, Korpole S Sci Rep. 2017; 7:46541.
PMID: 28422156 PMC: 5396196. DOI: 10.1038/srep46541.
Brevibacillus laterosporus, a Pathogen of Invertebrates and a Broad-Spectrum Antimicrobial Species.
Ruiu L Insects. 2015; 4(3):476-92.
PMID: 26462431 PMC: 4553477. DOI: 10.3390/insects4030476.
de Oliveira E, Rabinovitch L, Monnerat R, Passos L, Zahner V Appl Environ Microbiol. 2004; 70(11):6657-64.
PMID: 15528531 PMC: 525142. DOI: 10.1128/AEM.70.11.6657-6664.2004.